Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
Hypothiocyanite
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/19/2021
Icariin
Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020
Indole-3-carbinol
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/24/2021
Interferon gamma
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/05/2021
Interferon lambda-1
Potential treatment - pre-clinical evidence Natural product Antiviral Sep/15/2020
Ipomoeassin F
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/19/2021
Isohypericin
Potential treatment - theoretical effect Natural product Antiviral Mar/02/2021
Isorhamnetin
Potential treatment - theoretical effect Natural product Antiviral Dec/30/2020
Isorientin 4′-O-glucoside 2″-O-p-hydroxybenzoagte
Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020
Kaempferol
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021
Karuquinone B
Potential treatment - theoretical effect Natural product Antiviral Nov/16/2020
Kazinol F
Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020
Kazinol J
Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020
KFVPKQPNMIL
Potential treatment - theoretical effect Natural product Antiviral Dec/11/2020
Khainaoside B
Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020
Khainaoside C
Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020
L-Carnitine
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/14/2021
L-pyroglutamic acid
Potential treatment - theoretical effect Natural product Antiviral Aug/01/2020
Lactoferrin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/23/2021
Lariciresinol
Potential treatment - theoretical effect Natural product Antiviral Oct/06/2020